Geode Capital Management’s TScan Therapeutics TCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $822K | Sell |
|
|||||
|
2025
Q1 | $1.4M | Buy |
|
|||||
|
2024
Q4 | $2.93M | Sell |
|
|||||
|
2024
Q3 | $4.85M | Buy |
|
|||||
|
2024
Q2 | $5.27M | Buy |
|
|||||
|
2024
Q1 | $3.29M | Buy |
|
|||||
|
2023
Q4 | $2.28M | Buy |
|
|||||
|
2023
Q3 | $789K | Buy |
|
|||||
|
2023
Q2 | $292K | Buy |
|
|||||
|
2023
Q1 | $211K | Hold |
|
|||||
|
2022
Q4 | $163K | Sell |
|
|||||
|
2022
Q3 | $307K | Buy |
|
|||||
|
2022
Q2 | $107K | Buy |
|
|||||
|
2022
Q1 | $92K | Buy |
|
|||||
|
2021
Q4 | $114K | Buy |
|
|||||
|
2021
Q3 | $106K | Buy |
|